寻求、测试和治疗干预措施以减少沙眼衣原体差异
寻求、测试和治疗干预措施，以减少生活在南方腹地的黑人青年沙眼衣原体差异
This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：Patricia Kissinger, PhD
- 电话号码：504-988-7320
- 邮箱：kissing@tulane.edu
学习地点
-
-
Louisiana
-
New Orleans、Louisiana、美国、70112
- 招聘中
- Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine
-
接触：
- Momi Sagoe, MPH
- 电话号码：504-988-1049
- 邮箱：msagoe@tulane.edu
-
接触：
- Patricia Kissinger, PhD
- 电话号码：504-988-7320
- 邮箱：kissing@tulane.edu
-
首席研究员：
- Patricia Kissinger, PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Identifies as African American or Black
- 15-26 years of age
- Lives or spends most of their time in Orleans Parish
- Had vaginal sex at least once
- Provide a urine or vaginal swab
- Not taken azithromycin or cefixime in the last 7 days
Exclusion Criteria:
- Unwilling or unable to provide informed consent
- Unable to speak or understand English
- Previously enrolled in the study
学习计划
研究是如何设计的？
设计细节
- 主要用途：放映
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Chlamydia, gonorrhea, syphilis, and HIV screening
Community screening of individuals for chlamydia and gonorrhea is not normally done. We are testing to see if this intervention will impact the rates of chlamydia among women. |
Individuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment. |
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Rate of chlamydia in women
大体时间：up to 60 months
|
Primary outcome |
up to 60 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Index participant medication pickup rate
大体时间：up to 60 months
|
Percentage of index participants who obtain their prescribed medication from a partnering pharmacy among all index participants who report intending to pick up the medication. Medication receipt will be determined from pharmacy billing records. Rates will be calculated monthly. |
up to 60 months
|
|
Partner medication pickup rate
大体时间：60 months
|
Percentage of partners who obtain their prescribed medication from a partnering pharmacy among all partners reported as intending to pick up the medication. Medication receipt will be determined from pharmacy billing records. Rates will be calculated monthly. |
60 months
|
|
Self reported treatment of index participants and partners
大体时间：60 months
|
Number and percentage of index participants who report that they and all applicable partner(s) received treatment. The denominator will include index participants who provide follow-up information about their own and their partner(s)' treatment status. |
60 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2024-377
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
We will provide de-identified data to persons who submit a reasonable request with appropriate institutional approval after the primary and secondary request questions have been published.
IPD 共享时间框架
IPD and supporting information will be available from 2030 to 2033 (3 years).
IPD 共享访问标准
Any person with IRB approval from their institution who has a coherent plan for analysis can be provided with a CSV file and coding guide in a de-identified format.
IPD 共享支持信息类型
- 树液
- 国际碳纤维联合会
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.